Answers are grounded in this paper and cite their sources.
This review highlights drug repurposing potentials in existing treatments, suggesting knowledge graphs may enhance predictions using machine and deep learning.
Drug repurposing, the development of new therapeutic indications for existing drugs, is a promising strategy in drug development. Computational methods and artificial intelligence may be used to identify new drug repurposing candidates. Knowledge graph (KG) based methods have emerged as powerful tools for modeling and predicting drug-disease relationships, because of their intuitive way of exploiting biomedical knowledge and data. This review provides an overview of computational drug repurposing methods based on KGs. The motivation for adopting KG-based knowledge representations, traditional machine learning and deep learning approaches are discussed, followed by an analysis of selected tools, their construction, link prediction capabilities, and inherent advantages and limitations.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: